0001181431-14-001349.txt : 20140106 0001181431-14-001349.hdr.sgml : 20140106 20140106164022 ACCESSION NUMBER: 0001181431-14-001349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140102 FILED AS OF DATE: 20140106 DATE AS OF CHANGE: 20140106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAPLIN DAVID CENTRAL INDEX KEY: 0001167232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 14510469 4 1 rrd399155.xml CHAPLIN FORM 4 X0306 4 2014-01-02 0 0000908259 OXIGENE INC OXGN 0001167232 CHAPLIN DAVID C/O OXIGENE, INC. 701 GATEWAY BLVD, SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 2.79 2014-01-02 4 A 0 4880 0 A 2014-01-02 2020-01-02 Common Stock 4880 4880 D Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Director services to be provided through the first six months of 2014. The Stock Options were fully vested as of the grant date. /s/ Megan N. Gates, Attorney-in-fact 2014-01-06